EPISCREEN
Live / Registered — Registered — partial Section 8 accepted (as of 30 Sept 2023)
What this means for you
Registered since 06 Dec 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86716415
- Registration number
- 5093688
- Mark type
- Stylized text
- Filed
- 06 Aug 2015
- Published for opposition
- 28 Jun 2016
- Registered
- 06 Dec 2016
- Attorney of record
- Joyce von Natzmer
Goods and services
- Class 005 — Pharmaceuticals: [ Pharmaceuticals and pharmaceutical preparations used to treat cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; chemical preparations for medical or pharmaceutical purposes, namely, chemicals sold as integral component parts of pharmaceutical preparations for the treatment of cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; chemico-pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; vaccines; pharmaceutical preparations for skin care ]
- Class 042 — Scientific and technological services: Scientific research and product development services in relation to pharmaceutical and medical products; pharmaceutical research services; pharmaceutical product evaluation; testing of pharmaceuticals, namely, assessing the potential immunogenicity of proteins and antibodies by measuring immune cell responses to the pharmaceutical; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; provision of scientific information in the fields of cancer, diseases and disorders of the immune system, viral diseases and disorders, inflammatory diseases, fibrotic diseases, pulmonary diseases, gastro-intestinal diseases and disorders, haematological diseases and disorders, neurological diseases and disorders, pain, obesity, diabetes and graft rejection; toxicology services; provision of scientific information relating to the chemical industry, namely, information on the subject of chemical product development
- Class 044 — Medical, beauty and agricultural services: Medical services, namely, providing medical information regarding pharmaceuticals; Pharmacy and health advice; pharmaceutical services and provision of pharmaceutical information, all in the nature of providing medical information regarding pharmaceuticals; Medical screening; Medical screening to assess the potential immunogenicity of therapeutic antibodies and proteins
Owner
- ABZENA (UK) LIMITED, CAMBRIDGE, GB
- Polytherics Limited, Cambridge, GB
- Polytherics Limited, Cambridge, GB
- Polytherics Limited, Cambridge, GB
Prosecution history
- 06 Dec 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 30 Sept 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 30 Sept 2023 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
- 22 Sept 2023 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 02 Jun 2023 — POST REGISTRATION ACTION MAILED - SEC. 8
- 02 Jun 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Dec 2022 — TEAS SECTION 8 RECEIVED
- 06 Dec 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 31 Jul 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 06 Dec 2016 — REGISTERED-PRINCIPAL REGISTER
- 31 Oct 2016 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 11 Oct 2016 — NOTICE OF ALLOWANCE CANCELLED
- 30 Oct 2016 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Oct 2016 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 23 Aug 2016 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT